BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28800782)

  • 1. Effects of Chinese medicinal herbs on expression of brain-derived Neurotrophic factor (BDNF) and its interaction with human breast cancer MDA-MB-231 cells and endothelial HUVECs.
    Chiu JH; Chen FP; Tsai YF; Lin MT; Tseng LM; Shyr YM
    BMC Complement Altern Med; 2017 Aug; 17(1):401. PubMed ID: 28800782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
    Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
    PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ProBDNF is a Novel Mediator of the Interaction Between MDA-MB- 231 Breast Cancer Cells and Brain Microvascular Endothelial Cells.
    Alhusban L; Ayoub NM; Alhusban A
    Curr Mol Med; 2021; 21(10):914-921. PubMed ID: 33222669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
    Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
    BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on effect of naringenin in inhibiting migration and invasion of breast cancer cells and its molecular mechanism].
    Sun Y; Gu J
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1144-50. PubMed ID: 26226761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human multiple myeloma cell line RPMI8226 activates brain derived neurotrophic factor autocrine loop of co-cultured endothelial cells].
    Wang YD; Hu Y; Sun CY; He WJ; Zhang XP
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):235-8. PubMed ID: 17877199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on inhibitory effect of wogonin on proliferation and invasion of breast cancer cells].
    Huang KF; Zhuang Y; Huang YQ; Diao Y
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1485-9. PubMed ID: 25039187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism].
    Wang M; Cui HX; Sun C; Li G; Wang HL; Xia CH; Wang YC; Liu JC
    Yao Xue Xue Bao; 2016 Apr; 51(4):558-62. PubMed ID: 29859524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells.
    Wang L; Ling Y; Chen Y; Li CL; Feng F; You QD; Lu N; Guo QL
    Cancer Lett; 2010 Nov; 297(1):42-8. PubMed ID: 20580866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.
    Farzaneh Behelgardi M; Zahri S; Gholami Shahvir Z; Mashayekhi F; Mirzanejad L; Asghari SM
    Mol Biol Rep; 2020 Mar; 47(3):2061-2071. PubMed ID: 32072404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor.
    Paquette B; Therriault H; Desmarais G; Wagner R; Royer R; Bujold R
    Br J Cancer; 2011 Aug; 105(4):534-41. PubMed ID: 21792195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
    Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
    Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
    Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
    Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells.
    Gialeli Ch; Viola M; Barbouri D; Kletsas D; Passi A; Karamanos NK
    Biochim Biophys Acta; 2014 Aug; 1840(8):2549-59. PubMed ID: 24582970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of endothelial adherens junction by invasive breast cancer cells is mediated by reactive oxygen species and is attenuated by AHCC.
    Haidari M; Zhang W; Wakame K
    Life Sci; 2013 Dec; 93(25-26):994-1003. PubMed ID: 24211779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture supernatants of breast cancer cell line MDA-MB-231 treated with parthenolide inhibit the proliferation, migration, and lumen formation capacity of human umbilical vein endothelial cells.
    Li CJ; Guo SF; Shi TM
    Chin Med J (Engl); 2012 Jun; 125(12):2195-9. PubMed ID: 22884152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
    Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
    J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
    Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
    J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Contreras-Zárate MJ; Day NL; Ormond DR; Borges VF; Tobet S; Gril B; Steeg PS; Cittelly DM
    Oncogene; 2019 Jun; 38(24):4685-4699. PubMed ID: 30796353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.